TOT BIOPHARM International Co. Ltd. (1875) Stock Statistics & Valuation Metrics

TOT BIOPHARM International Co. Ltd. has a market cap or net worth of HKD 2.56B. The enterprise value is HKD 2.48B.

Market Cap

HKD 2.56B

Enterprise Value

HKD 2.48B

TOT BIOPHARM International Co. Ltd. has 772,787,900 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

772,787,900

Owned by Insiders

―

Owned by Institutions

―

TOT BIOPHARM International Co. Ltd.’s return on equity (ROE) is -0.16 and return on invested capital (ROIC) is -8.71%.

Return on Equity (ROE)

-0.16

Return on Assets (ROA)

-0.08

Return on Invested Capital (ROIC)

-8.71%

Return on Capital Employed (ROCE)

-0.09

Revenue Per Employee

1.25M

Profits Per Employee

-168.40K

Employee Count

596

Asset Turnover

0.59

Inventory Turnover

3.39

The current PE Ratio of TOT BIOPHARM International Co. Ltd. is -12.76. TOT BIOPHARM International Co. Ltd.’s PEG ratio is 0.03.

PE Ratio

-12.76

PS Ratio

4.06

PB Ratio

3.31

Price to FCF

-21.53

Price to Operating Cash Flow

-30.75

PEG Ratio

0.03

In the last 12 months, TOT BIOPHARM International Co. Ltd. had revenue of 747.64M and earned -100.37M in profits. Earnings per share was -0.14.

Revenue

747.64M

Gross Profit

388.98M

Operating Income

-90.69M

Pretax Income

-100.37M

Net Income

-100.37M

EBITDA

-1.29M

Earnings Per Share (EPS)

-0.14

In the last 12 months, operating cash flow was -66.11M and capital expenditures -28.28M, giving a free cash flow of -94.39M billion.

Operating Cash Flow

-66.11M

Free Cash Flow

-94.39M

Free Cash Flow per Share

-0.13

TOT BIOPHARM International Co. Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share

―

Dividend Yield

―

Payout Ratio

N/A

Free Cash Flow Yield

-4.64%

Earnings Yield

-7.98%

Beta

0.79

52-Week Price Change

66.33%

50-Day Moving Average

3.71

200-Day Moving Average

4.02

Relative Strength Index (RSI)

37.26

Average Volume (3m)

566.22K

TOT BIOPHARM International Co. Ltd. upcoming earnings date is Mar 25, 2027, TBA (Not Confirmed).

Last Earnings Date

Aug 21, 2026

Next Earnings Date

Mar 25, 2027

Ex-Dividend Date

―

TOT BIOPHARM International Co. Ltd. as a current ratio of 2.05, with Debt / Equity ratio of 61.29%

Current Ratio

2.05

Quick Ratio

1.66

Debt to Market Cap

0.24

Net Debt to EBITDA

-42.86

Interest Coverage Ratio

-7.61

In the past 12 months, TOT BIOPHARM International Co. Ltd. has paid 0 in taxes.

Income Tax

0

Effective Tax Rate

0.00

TOT BIOPHARM International Co. Ltd. EV to EBITDA ratio is -51.52, with an EV/FCF ratio of -22.46.

EV to Sales

4.23

EV to EBITDA

-51.52

EV to Free Cash Flow

-22.46

EV to Operating Cash Flow

-32.06

TOT BIOPHARM International Co. Ltd. has HKD 263.69M in cash and marketable securities with HKD 350.93M in debt, giving a net cash position of -HKD 87.24M billion.

Cash & Marketable Securities

HKD 263.69M

Total Debt

HKD 350.93M

Net Cash

-HKD 87.24M

Net Cash Per Share

-HKD 0.11

Tangible Book Value Per Share

HKD 0.83

Gross margin is 17.53%, with operating margin of -30.68%, and net profit margin of -32.36%.

Gross Margin

17.53%

Operating Margin

-30.68%

Pretax Margin

-32.36%

Net Profit Margin

-32.36%

EBITDA Margin

-8.21%

EBIT Margin

-28.58%

The average price target for TOT BIOPHARM International Co. Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target

―

Price Target Upside

―

Analyst Consensus

―

Analyst Count

―

Revenue Growth Forecast

-51.10%

EPS Growth Forecast

-2384.76%

Smart Score

6

AI Score

49